nodes	percent_of_prediction	percent_of_DWPC	metapath
Vismodegib—ABCB1—adrenal gland cancer	0.83	1	CbGaD
Vismodegib—Sorafenib—BRAF—adrenal gland cancer	0.00557	0.445	CrCbGaD
Vismodegib—CYP2C19—urine—adrenal gland cancer	0.00334	0.151	CbGeAlD
Vismodegib—SMO—adrenal cortex—adrenal gland cancer	0.00286	0.13	CbGeAlD
Vismodegib—SMO—Integrated Pancreatic Cancer Pathway—DAXX—adrenal gland cancer	0.00285	0.021	CbGpPWpGaD
Vismodegib—SHH—Ectoderm Differentiation—SPRY2—adrenal gland cancer	0.00282	0.0208	CbGpPWpGaD
Vismodegib—SHH—Integrated Pancreatic Cancer Pathway—RRM1—adrenal gland cancer	0.0028	0.0206	CbGpPWpGaD
Vismodegib—ABCG2—Fluoropyrimidine Activity—RRM1—adrenal gland cancer	0.00271	0.02	CbGpPWpGaD
Vismodegib—SMO—Integrated Pancreatic Cancer Pathway—RRM1—adrenal gland cancer	0.00265	0.0195	CbGpPWpGaD
Vismodegib—CYP2C9—urine—adrenal gland cancer	0.00259	0.117	CbGeAlD
Vismodegib—SMO—Hedgehog 'off' state—PRKACA—adrenal gland cancer	0.00246	0.0181	CbGpPWpGaD
Vismodegib—Tolvaptan—ABCB1—adrenal gland cancer	0.00244	0.195	CrCbGaD
Vismodegib—SMO—cardiac atrium—adrenal gland cancer	0.00237	0.107	CbGeAlD
Vismodegib—SHH—Signaling by Hedgehog—PRKACA—adrenal gland cancer	0.00232	0.0171	CbGpPWpGaD
Vismodegib—SMO—pituitary gland—adrenal gland cancer	0.00231	0.105	CbGeAlD
Vismodegib—SHH—Class B/2 (Secretin family receptors)—GNAS—adrenal gland cancer	0.00231	0.0171	CbGpPWpGaD
Vismodegib—SMO—Signaling by Hedgehog—PRKACA—adrenal gland cancer	0.00219	0.0162	CbGpPWpGaD
Vismodegib—SMO—Class B/2 (Secretin family receptors)—GNAS—adrenal gland cancer	0.00219	0.0162	CbGpPWpGaD
Vismodegib—Etoricoxib—PTGS2—adrenal gland cancer	0.00218	0.174	CrCbGaD
Vismodegib—SMO—adrenal gland—adrenal gland cancer	0.00207	0.0937	CbGeAlD
Vismodegib—SHH—GPCR ligand binding—GNRHR—adrenal gland cancer	0.00204	0.015	CbGpPWpGaD
Vismodegib—SMO—Hedgehog 'off' state—GNAS—adrenal gland cancer	0.00199	0.0147	CbGpPWpGaD
Vismodegib—SHH—Hair Follicle Development: Induction (Part 1 of 3)—CTNNB1—adrenal gland cancer	0.00199	0.0147	CbGpPWpGaD
Vismodegib—CYP3A4—urine—adrenal gland cancer	0.00197	0.0894	CbGeAlD
Vismodegib—SHH—Validated transcriptional targets of TAp63 isoforms—CDKN2A—adrenal gland cancer	0.00195	0.0143	CbGpPWpGaD
Vismodegib—SMO—GPCR ligand binding—GNRHR—adrenal gland cancer	0.00193	0.0142	CbGpPWpGaD
Vismodegib—SHH—Heart Development—CTNNB1—adrenal gland cancer	0.00192	0.0141	CbGpPWpGaD
Vismodegib—SMO—Hair Follicle Development: Induction (Part 1 of 3)—CTNNB1—adrenal gland cancer	0.00189	0.0139	CbGpPWpGaD
Vismodegib—SHH—Signaling by Hedgehog—GNAS—adrenal gland cancer	0.00188	0.0138	CbGpPWpGaD
Vismodegib—SMO—Signaling by Hedgehog—GNAS—adrenal gland cancer	0.00178	0.0131	CbGpPWpGaD
Vismodegib—SHH—Integrated Pancreatic Cancer Pathway—TOP2A—adrenal gland cancer	0.00173	0.0127	CbGpPWpGaD
Vismodegib—SMO—Integrated Pancreatic Cancer Pathway—TOP2A—adrenal gland cancer	0.00164	0.0121	CbGpPWpGaD
Vismodegib—SHH—Hair Follicle Development: Induction (Part 1 of 3)—EGFR—adrenal gland cancer	0.00158	0.0116	CbGpPWpGaD
Vismodegib—SMO—Hair Follicle Development: Induction (Part 1 of 3)—EGFR—adrenal gland cancer	0.00149	0.011	CbGpPWpGaD
Vismodegib—Sulfasalazine—PTGS2—adrenal gland cancer	0.00128	0.103	CrCbGaD
Vismodegib—SHH—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00122	0.00899	CbGpPWpGaD
Vismodegib—CYP3A4—Codeine and Morphine Metabolism—ABCB1—adrenal gland cancer	0.00121	0.00895	CbGpPWpGaD
Vismodegib—SHH—Integrated Pancreatic Cancer Pathway—ABCB1—adrenal gland cancer	0.00121	0.00892	CbGpPWpGaD
Vismodegib—SMO—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00116	0.00852	CbGpPWpGaD
Vismodegib—SMO—Integrated Pancreatic Cancer Pathway—ABCB1—adrenal gland cancer	0.00115	0.00846	CbGpPWpGaD
Vismodegib—SHH—GPCR ligand binding—TSHR—adrenal gland cancer	0.00109	0.00802	CbGpPWpGaD
Vismodegib—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—PRKACA—adrenal gland cancer	0.00108	0.00793	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00104	0.0077	CbGpPWpGaD
Vismodegib—SMO—GPCR ligand binding—TSHR—adrenal gland cancer	0.00103	0.0076	CbGpPWpGaD
Vismodegib—Sorafenib—ABCB1—adrenal gland cancer	0.00103	0.0824	CrCbGaD
Vismodegib—SMO—Signaling by GPCR—GNRHR—adrenal gland cancer	0.000991	0.0073	CbGpPWpGaD
Vismodegib—ALB—Binding and Uptake of Ligands by Scavenger Receptors—SPARC—adrenal gland cancer	0.000906	0.00668	CbGpPWpGaD
Vismodegib—SHH—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	0.000901	0.00664	CbGpPWpGaD
Vismodegib—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—ABCB1—adrenal gland cancer	0.000855	0.0063	CbGpPWpGaD
Vismodegib—SMO—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	0.000854	0.00629	CbGpPWpGaD
Vismodegib—SHH—Disease—SH3KBP1—adrenal gland cancer	0.00082	0.00604	CbGpPWpGaD
Vismodegib—ALB—adrenal gland—adrenal gland cancer	0.000792	0.0359	CbGeAlD
Vismodegib—SHH—Disease—ZNRF3—adrenal gland cancer	0.00077	0.00568	CbGpPWpGaD
Vismodegib—SHH—Ectoderm Differentiation—CTNNB1—adrenal gland cancer	0.000768	0.00566	CbGpPWpGaD
Vismodegib—ABCG2—adrenal cortex—adrenal gland cancer	0.00075	0.034	CbGeAlD
Vismodegib—ABCG2—HIF-1-alpha transcription factor network—ABCB1—adrenal gland cancer	0.000674	0.00497	CbGpPWpGaD
Vismodegib—CYP2C19—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.000666	0.00491	CbGpPWpGaD
Vismodegib—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—adrenal gland cancer	0.000664	0.0049	CbGpPWpGaD
Vismodegib—SHH—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	0.000662	0.00488	CbGpPWpGaD
Vismodegib—ALB—Lipid and lipoprotein metabolism—PRKACA—adrenal gland cancer	0.000653	0.00481	CbGpPWpGaD
Vismodegib—SHH—GPCR ligand binding—GNAS—adrenal gland cancer	0.000632	0.00466	CbGpPWpGaD
Vismodegib—SMO—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	0.000628	0.00463	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—GNRH1—adrenal gland cancer	0.000626	0.00461	CbGpPWpGaD
Vismodegib—CYP2C8—pituitary gland—adrenal gland cancer	0.000623	0.0282	CbGeAlD
Vismodegib—SHH—Signaling Pathways—GNRHR—adrenal gland cancer	0.000617	0.00455	CbGpPWpGaD
Vismodegib—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.000607	0.00448	CbGpPWpGaD
Vismodegib—ABCG2—pituitary gland—adrenal gland cancer	0.000606	0.0275	CbGeAlD
Vismodegib—SMO—GPCR ligand binding—GNAS—adrenal gland cancer	0.0006	0.00442	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—GNRH1—adrenal gland cancer	0.000593	0.00437	CbGpPWpGaD
Vismodegib—SHH—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	0.000592	0.00437	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—GNRHR—adrenal gland cancer	0.000585	0.00431	CbGpPWpGaD
Vismodegib—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PRKACA—adrenal gland cancer	0.000581	0.00428	CbGpPWpGaD
Vismodegib—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.000579	0.00426	CbGpPWpGaD
Vismodegib—ABCG2—HIF-1-alpha transcription factor network—TERT—adrenal gland cancer	0.000576	0.00425	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.000574	0.00423	CbGpPWpGaD
Vismodegib—SMO—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	0.000562	0.00414	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—TSHR—adrenal gland cancer	0.000558	0.00411	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.000544	0.00401	CbGpPWpGaD
Vismodegib—ABCG2—adrenal gland—adrenal gland cancer	0.000541	0.0245	CbGeAlD
Vismodegib—SHH—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00054	0.00398	CbGpPWpGaD
Vismodegib—ALB—Platelet degranulation—SPARC—adrenal gland cancer	0.000531	0.00391	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—TSHR—adrenal gland cancer	0.000529	0.0039	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—ZNRF3—adrenal gland cancer	0.000511	0.00377	CbGpPWpGaD
Vismodegib—ALB—Response to elevated platelet cytosolic Ca2+—SPARC—adrenal gland cancer	0.000506	0.00373	CbGpPWpGaD
Vismodegib—SHH—Disease—SPRY2—adrenal gland cancer	0.000483	0.00356	CbGpPWpGaD
Vismodegib—SHH—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	0.000469	0.00346	CbGpPWpGaD
Vismodegib—SMO—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	0.000445	0.00328	CbGpPWpGaD
Vismodegib—SHH—Disease—MEN1—adrenal gland cancer	0.000443	0.00326	CbGpPWpGaD
Vismodegib—SHH—GPCR ligand binding—POMC—adrenal gland cancer	0.000426	0.00314	CbGpPWpGaD
Vismodegib—SMO—GPCR ligand binding—POMC—adrenal gland cancer	0.000404	0.00298	CbGpPWpGaD
Vismodegib—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.0004	0.00295	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—PRKACA—adrenal gland cancer	0.0004	0.00295	CbGpPWpGaD
Vismodegib—SHH—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	0.000394	0.00291	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—DAXX—adrenal gland cancer	0.000387	0.00285	CbGpPWpGaD
Vismodegib—ABCG2—Fluoropyrimidine Activity—TP53—adrenal gland cancer	0.000382	0.00282	CbGpPWpGaD
Vismodegib—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.000382	0.00281	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00038	0.0028	CbGpPWpGaD
Vismodegib—SMO—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	0.000374	0.00275	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—GNRH1—adrenal gland cancer	0.00037	0.00273	CbGpPWpGaD
Vismodegib—ABCB1—adrenal cortex—adrenal gland cancer	0.00037	0.0168	CbGeAlD
Vismodegib—ALB—Platelet degranulation—IGF2—adrenal gland cancer	0.000366	0.0027	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—adrenal gland cancer	0.00036	0.00265	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—GNRH1—adrenal gland cancer	0.000351	0.00258	CbGpPWpGaD
Vismodegib—ALB—Response to elevated platelet cytosolic Ca2+—IGF2—adrenal gland cancer	0.000349	0.00257	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—CDC42—adrenal gland cancer	0.00034	0.0025	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—SPRY2—adrenal gland cancer	0.000338	0.00249	CbGpPWpGaD
Vismodegib—SHH—Disease—PRKACA—adrenal gland cancer	0.000338	0.00249	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—TSHR—adrenal gland cancer	0.00033	0.00243	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—GNAS—adrenal gland cancer	0.000325	0.00239	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—CDC42—adrenal gland cancer	0.000322	0.00237	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—SPRY2—adrenal gland cancer	0.000321	0.00236	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—TSHR—adrenal gland cancer	0.000312	0.0023	CbGpPWpGaD
Vismodegib—ABCB1—HIF-1-alpha transcription factor network—TERT—adrenal gland cancer	0.000312	0.0023	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—MEN1—adrenal gland cancer	0.00031	0.00228	CbGpPWpGaD
Vismodegib—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00031	0.00228	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—GNAS—adrenal gland cancer	0.000308	0.00227	CbGpPWpGaD
Vismodegib—ABCB1—gonad—adrenal gland cancer	0.000306	0.0139	CbGeAlD
Vismodegib—ABCB1—pituitary gland—adrenal gland cancer	0.000299	0.0135	CbGeAlD
Vismodegib—SMO—Signaling Pathways—MEN1—adrenal gland cancer	0.000294	0.00217	CbGpPWpGaD
Vismodegib—SHH—Disease—CDC42—adrenal gland cancer	0.000287	0.00211	CbGpPWpGaD
Vismodegib—CYP2C8—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.000286	0.00211	CbGpPWpGaD
Vismodegib—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.000276	0.00204	CbGpPWpGaD
Vismodegib—ABCB1—adrenal gland—adrenal gland cancer	0.000267	0.0121	CbGeAlD
Vismodegib—CYP2C19—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.000255	0.00188	CbGpPWpGaD
Vismodegib—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.000252	0.00186	CbGpPWpGaD
Vismodegib—CYP2C8—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000251	0.00185	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—PRKACA—adrenal gland cancer	0.000237	0.00174	CbGpPWpGaD
Vismodegib—ALB—Platelet activation, signaling and aggregation—SPARC—adrenal gland cancer	0.000236	0.00174	CbGpPWpGaD
Vismodegib—CYP2C9—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.000233	0.00171	CbGpPWpGaD
Vismodegib—SHH—Disease—TERT—adrenal gland cancer	0.00023	0.00169	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—PRKACA—adrenal gland cancer	0.000224	0.00165	CbGpPWpGaD
Vismodegib—CYP2C19—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000224	0.00165	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—adrenal gland cancer	0.000222	0.00164	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—POMC—adrenal gland cancer	0.000219	0.00161	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—POMC—adrenal gland cancer	0.000207	0.00153	CbGpPWpGaD
Vismodegib—CYP2C9—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000204	0.00151	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—CDC42—adrenal gland cancer	0.000201	0.00148	CbGpPWpGaD
Vismodegib—SHH—Disease—BAD—adrenal gland cancer	0.0002	0.00147	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—IGF2—adrenal gland cancer	0.000193	0.00143	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—SDHB—adrenal gland cancer	0.000192	0.00142	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—GNAS—adrenal gland cancer	0.000192	0.00141	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—CDC42—adrenal gland cancer	0.00019	0.0014	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—IGF1R—adrenal gland cancer	0.000187	0.00138	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—IGF2—adrenal gland cancer	0.000183	0.00135	CbGpPWpGaD
Vismodegib—SHH—Disease—BRAF—adrenal gland cancer	0.000182	0.00134	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—GNAS—adrenal gland cancer	0.000182	0.00134	CbGpPWpGaD
Vismodegib—ALB—Selenium Micronutrient Network—PTGS2—adrenal gland cancer	0.000181	0.00133	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—IGF1R—adrenal gland cancer	0.000177	0.00131	CbGpPWpGaD
Vismodegib—ALB—Platelet activation, signaling and aggregation—CDC42—adrenal gland cancer	0.000169	0.00124	CbGpPWpGaD
Vismodegib—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.000166	0.00123	CbGpPWpGaD
Vismodegib—ALB—Platelet activation, signaling and aggregation—IGF2—adrenal gland cancer	0.000163	0.0012	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—TERT—adrenal gland cancer	0.000161	0.00119	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—TERT—adrenal gland cancer	0.000153	0.00112	CbGpPWpGaD
Vismodegib—SHH—Disease—PTGS2—adrenal gland cancer	0.000147	0.00108	CbGpPWpGaD
Vismodegib—ABCG2—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.000144	0.00106	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—BAD—adrenal gland cancer	0.00014	0.00103	CbGpPWpGaD
Vismodegib—ALB—Folate Metabolism—TP53—adrenal gland cancer	0.000135	0.000998	CbGpPWpGaD
Vismodegib—CYP3A4—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000135	0.000993	CbGpPWpGaD
Vismodegib—CYP2C8—Biological oxidations—POMC—adrenal gland cancer	0.000133	0.000983	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—BAD—adrenal gland cancer	0.000133	0.000979	CbGpPWpGaD
Vismodegib—SHH—Disease—CTNNB1—adrenal gland cancer	0.000132	0.00097	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—POMC—adrenal gland cancer	0.000129	0.000952	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000129	0.000948	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000128	0.000943	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—BRAF—adrenal gland cancer	0.000127	0.00094	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—RRM1—adrenal gland cancer	0.000124	0.000913	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—SDHD—adrenal gland cancer	0.000124	0.000913	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—EGFR—adrenal gland cancer	0.000124	0.000911	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—POMC—adrenal gland cancer	0.000122	0.000902	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—SPARC—adrenal gland cancer	0.000121	0.000895	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—BRAF—adrenal gland cancer	0.000121	0.000891	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—SDHB—adrenal gland cancer	0.000119	0.000879	CbGpPWpGaD
Vismodegib—CYP2C19—Biological oxidations—POMC—adrenal gland cancer	0.000119	0.000877	CbGpPWpGaD
Vismodegib—ALB—Metabolism—SDHB—adrenal gland cancer	0.000119	0.000874	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—EGFR—adrenal gland cancer	0.000117	0.000863	CbGpPWpGaD
Vismodegib—ABCG2—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000117	0.000859	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	0.000116	0.000854	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000115	0.000846	CbGpPWpGaD
Vismodegib—ABCG2—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000114	0.000843	CbGpPWpGaD
Vismodegib—CYP2C9—Biological oxidations—POMC—adrenal gland cancer	0.000109	0.0008	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—SDHB—adrenal gland cancer	0.000106	0.000784	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000105	0.000772	CbGpPWpGaD
Vismodegib—SHH—Disease—EGFR—adrenal gland cancer	0.000104	0.000768	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—SDHB—adrenal gland cancer	0.000104	0.000766	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—PRKACA—adrenal gland cancer	0.000102	0.000755	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—SDHB—adrenal gland cancer	9.7e-05	0.000715	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	9.38e-05	0.000692	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	9.33e-05	0.000688	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—MED12—adrenal gland cancer	9.23e-05	0.00068	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—CTNNB1—adrenal gland cancer	9.21e-05	0.000679	CbGpPWpGaD
Vismodegib—ALB—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	8.87e-05	0.000654	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—CTNNB1—adrenal gland cancer	8.73e-05	0.000644	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—CDC42—adrenal gland cancer	8.69e-05	0.000641	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	8.52e-05	0.000628	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—IGF2—adrenal gland cancer	8.38e-05	0.000618	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	8.37e-05	0.000617	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—GNAS—adrenal gland cancer	8.31e-05	0.000612	CbGpPWpGaD
Vismodegib—ABCB1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	7.77e-05	0.000573	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—RRM1—adrenal gland cancer	7.68e-05	0.000566	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—SDHD—adrenal gland cancer	7.68e-05	0.000566	CbGpPWpGaD
Vismodegib—ALB—Metabolism—SDHD—adrenal gland cancer	7.64e-05	0.000563	CbGpPWpGaD
Vismodegib—ALB—Metabolism—RRM1—adrenal gland cancer	7.64e-05	0.000563	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	7.64e-05	0.000563	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	7.62e-05	0.000562	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—EGFR—adrenal gland cancer	7.3e-05	0.000538	CbGpPWpGaD
Vismodegib—ALB—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	7.19e-05	0.00053	CbGpPWpGaD
Vismodegib—CYP3A4—Biological oxidations—POMC—adrenal gland cancer	7.16e-05	0.000528	CbGpPWpGaD
Vismodegib—ALB—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	7.05e-05	0.00052	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—EGFR—adrenal gland cancer	6.92e-05	0.00051	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—SDHD—adrenal gland cancer	6.86e-05	0.000505	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—RRM1—adrenal gland cancer	6.86e-05	0.000505	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—PRKACA—adrenal gland cancer	6.73e-05	0.000496	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—SDHD—adrenal gland cancer	6.69e-05	0.000493	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—RRM1—adrenal gland cancer	6.69e-05	0.000493	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—SDHB—adrenal gland cancer	6.4e-05	0.000472	CbGpPWpGaD
Vismodegib—ABCB1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	6.3e-05	0.000464	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—RRM1—adrenal gland cancer	6.25e-05	0.000461	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—SDHD—adrenal gland cancer	6.25e-05	0.000461	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—TP53—adrenal gland cancer	6.13e-05	0.000452	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	6.04e-05	0.000445	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—TP53—adrenal gland cancer	5.81e-05	0.000428	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—MED12—adrenal gland cancer	5.73e-05	0.000422	CbGpPWpGaD
Vismodegib—ALB—Metabolism—MED12—adrenal gland cancer	5.69e-05	0.00042	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—GNAS—adrenal gland cancer	5.46e-05	0.000402	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—ABCB1—adrenal gland cancer	5.35e-05	0.000395	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	5.12e-05	0.000377	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—MED12—adrenal gland cancer	5.11e-05	0.000377	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	5.09e-05	0.000375	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	5.07e-05	0.000374	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—MED12—adrenal gland cancer	4.99e-05	0.000368	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—MED12—adrenal gland cancer	4.66e-05	0.000344	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	4.57e-05	0.000337	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—PRKACA—adrenal gland cancer	4.18e-05	0.000308	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	4.17e-05	0.000307	CbGpPWpGaD
Vismodegib—ALB—Metabolism—PRKACA—adrenal gland cancer	4.15e-05	0.000306	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—SDHD—adrenal gland cancer	4.12e-05	0.000304	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—RRM1—adrenal gland cancer	4.12e-05	0.000304	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	4.08e-05	0.000301	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	4.06e-05	0.000299	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—PRKACA—adrenal gland cancer	3.73e-05	0.000275	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—POMC—adrenal gland cancer	3.67e-05	0.000271	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	3.65e-05	0.000269	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—PRKACA—adrenal gland cancer	3.64e-05	0.000268	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—PRKACA—adrenal gland cancer	3.4e-05	0.000251	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—GNAS—adrenal gland cancer	3.39e-05	0.00025	CbGpPWpGaD
Vismodegib—ALB—Metabolism—GNAS—adrenal gland cancer	3.37e-05	0.000248	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	3.32e-05	0.000245	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—ABCB1—adrenal gland cancer	3.32e-05	0.000245	CbGpPWpGaD
Vismodegib—ALB—Metabolism—ABCB1—adrenal gland cancer	3.3e-05	0.000244	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—MED12—adrenal gland cancer	3.07e-05	0.000227	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—GNAS—adrenal gland cancer	3.02e-05	0.000223	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—ABCB1—adrenal gland cancer	2.97e-05	0.000219	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—GNAS—adrenal gland cancer	2.95e-05	0.000217	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—PTGS2—adrenal gland cancer	2.93e-05	0.000216	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—GNAS—adrenal gland cancer	2.76e-05	0.000203	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—ABCB1—adrenal gland cancer	2.7e-05	0.000199	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—TP53—adrenal gland cancer	2.65e-05	0.000196	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—POMC—adrenal gland cancer	2.28e-05	0.000168	CbGpPWpGaD
Vismodegib—ALB—Metabolism—POMC—adrenal gland cancer	2.27e-05	0.000167	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	2.24e-05	0.000165	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—POMC—adrenal gland cancer	2.04e-05	0.00015	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—POMC—adrenal gland cancer	1.99e-05	0.000146	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—POMC—adrenal gland cancer	1.86e-05	0.000137	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—PTGS2—adrenal gland cancer	1.82e-05	0.000134	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—GNAS—adrenal gland cancer	1.82e-05	0.000134	CbGpPWpGaD
Vismodegib—ALB—Metabolism—PTGS2—adrenal gland cancer	1.81e-05	0.000133	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	1.78e-05	0.000131	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—PTGS2—adrenal gland cancer	1.62e-05	0.00012	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—PTGS2—adrenal gland cancer	1.58e-05	0.000117	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—PTGS2—adrenal gland cancer	1.48e-05	0.000109	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—POMC—adrenal gland cancer	1.22e-05	9.02e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	9.76e-06	7.2e-05	CbGpPWpGaD
